Drug & intervention
canagliflozin 100 MG
RxCUI 1373459
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
7 shownA Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart FailureNCT04252287 · 2020-03-10
COMPLETEDA Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes MellitusNCT03170518 · 2017-07-21
COMPLETEDA Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)NCT02139943 · 2014-05-01
COMPLETEDA Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes MellitusNCT02000700 · 2014-03-01
COMPLETEDA Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseNCT01809327 · 2013-06-04
COMPLETEDA Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusNCT01106651 · 2010-06-01
COMPLETEDA Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes MellitusNCT01128985 · 2010-03-01
COMPLETEDConditions being studied
Research locations
HoustonTexas, United States5Little RockArkansas, United States4MiamiFlorida, United States4AlbuquerqueNew Mexico, United States3AtlantaGeorgia, United States3AuroraColorado, United States3AustinTexas, United States3DallasTexas, United States3Salt Lake CityUtah, United States3São PauloBrazil3Walnut CreekCalifornia, United States3BucharestRomania2
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.